Saturday, July 11, 2026

pharma · Chronic Hepatitis B

Sun Yat-sen University

Sun Yat-sen University clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
3,680 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
3,680
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Programs

Sun Yat-sen University projects

1 ClinicalTrials.gov programs sponsored by Sun Yat-sen University.

Sun Yat-sen University has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Peginterferon alfa

    Third Affiliated Hospital, Sun Yat-Sen University

    Chronic Hepatitis B

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Sun Yat-sen University have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.